James F. Casella

James F. Casella

Hematology
200 North Wolfe Street, Rubenstein BLDG Lower Level
Rubenstein BLDG Lower Level
Baltimore, MD 21287

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications

Conducting multicenter trials through the trial innovation network comprehensive consultation.

Conducting multicenter trials through the trial innovation network comprehensive consultation.

Journal: Contemporary clinical trials
Published: September 08, 2025

Enhancing Multicenter Trials With the Trial Innovation Network's Initial Consultation Process.

Enhancing Multicenter Trials With the Trial Innovation Network's Initial Consultation Process.

Journal: JAMA network open
Published: May 29, 2025

Insights from the trial innovation network's initial consultation process.

Insights from the trial innovation network's initial consultation process.

Journal: Journal of clinical and translational science
Published: April 11, 2025

Duration of anticoagulation for venous thromboembolism in pediatric patients: Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial outcomes at 2 years.

Duration of anticoagulation for venous thromboembolism in pediatric patients: Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial outcomes at 2 years.

Journal: Journal of thrombosis and haemostasis : JTH
Published: June 05, 2024

Hydroxyurea to prevent brain injury in children with sickle cell disease (HU Prevent)-A randomized, placebo-controlled phase II feasibility/pilot study.

Hydroxyurea to prevent brain injury in children with sickle cell disease (HU Prevent)-A randomized, placebo-controlled phase II feasibility/pilot study.

Journal: American journal of hematology
Published: February 29, 2024

FLT1 and other candidate fetal haemoglobin modifying loci in sickle cell disease in African ancestries.

FLT1 and other candidate fetal haemoglobin modifying loci in sickle cell disease in African ancestries.

Journal: Nature communications
Published: December 05, 2023

Lost and found, safe and sound: a case report surrounding the stabilization of a medically complex young adult patient with opioid use disorder through an acute wrapround care approach.

Lost and found, safe and sound: a case report surrounding the stabilization of a medically complex young adult patient with opioid use disorder through an acute wrapround care approach.

Journal: Journal of addictive diseases
Published: August 10, 2022

Current developmental screening practices in young children with sickle cell disease.

Current developmental screening practices in young children with sickle cell disease.

Journal: British journal of haematology
Published: July 20, 2022

Neurocognitive screening in sickle cell disease.

Neurocognitive screening in sickle cell disease.

Journal: Pediatric blood & cancer
Published: January 27, 2022

Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial.

Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial.

Journal: JAMA
Published: January 11, 2022

Brain Oxygen Extraction and Metabolism in Pediatric Patients With Sickle Cell Disease: Comparison of Four Calibration Models.

Brain Oxygen Extraction and Metabolism in Pediatric Patients With Sickle Cell Disease: Comparison of Four Calibration Models.

Journal: Frontiers in physiology
Published: November 14, 2021

Poloxamer 188 vs Placebo for Painful Vaso-occlusive Episodes in Children and Adults With Sickle Cell Disease-Reply.

Poloxamer 188 vs Placebo for Painful Vaso-occlusive Episodes in Children and Adults With Sickle Cell Disease-Reply.

Journal: JAMA
Published: September 14, 2021
Showing 1-12 of 65

Last Updated: 09/26/2026